Skip to main content
Ain-Shams Journal of Anesthesiology

Table 3 Comparison between the two groups as regards the age (in years), weight (in kilograms), and indication for UFH (in numbers)

From: The use of activated partial thromboplastin time versus antifactor Xa assay in monitoring continuous unfractionated heparin infusion therapy in obstetric intensive care unit

Parameter

Group P (n = 50)

Group X (n = 50)

p value

Age (years)

26.65 ± 4.5

24.84 ± 3.4

0.4776

Weight (kg)

83.2 ± 6.7

83.2 ± 8.6

0.98

Indications for UFH:

 Valvular heart disease

22

24

0.5277

 Atrial fibrillation

17

16

0.4807

 Anti-phospholipid syndrome

7

4

0.3305

 Venous thromboembolism

4

6

0.625

  1. Data presented as mean ± SD and numbers as appropriate, p value < 0.05 was considered statistically significant
Back to article page